Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Seongnam-si
Clinical trial register · South Korea

Clinical Trials in Seongnam-si, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3365 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:17 UTC
3365
Studies in scope
all four open statuses
1831
Recruiting now
open to new participants
500
Lead sponsors
across recruiting studies
Top sites
Seongnam-si 51 Seoul 4 Daegu 3 Hwasun 3 Gyeonggi-do 2
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca59 Seoul National University Bundang Hospital51 Hoffmann-La Roche24 Seoul National University Hospital20 Janssen Research & Development, LLC18 Clear sponsor filter
Site location
Seongnam-si51 Seoul4 Daegu3 Hwasun3 Gyeonggi-do2
All 19 locations
Target enrolment
to

Trials with a site in Seongnam-si

51 of 3365 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Not yet open
AI-ECG for Preoperative Cardiovascular Risk Stratification Before General Surgery
NCT07774689Perioperative Cardiovascular Risk, Postoperative Complications (Cardiopulmonary), Preoperative Care
Seoul National University Bundang Hospital
Not applicable
3,200
Seongnam-si
2026-09-01
Not yet open
Seoul National University Bundang Hospital
Phase 4
294
Seongnam-si
2026-09
By invitation
Seoul National University Bundang Hospital
Not applicable
150
Seongnam-si
2026-06-30
Not yet open
Remimazolam on the Incidence of Postoperative Acute Kidney Injury
NCT07674719Remimazolam, Propofol, Acute Kidney Injury, Hemodynamic Stability
DrugsRemimazolam·Propofol
Seoul National University Bundang Hospital
Not applicable
78
Seongnam-si
2026-06-26
By invitation
Seoul National University Bundang Hospital
Phase 1/2
93
Seongnam-si
2026-06-15
Recruiting
Seoul National University Bundang Hospital
Phase 4
1,200
Seongnam-si
2026-05-06
Not yet open
Exploratory Trial of the "HiDongDong" Language Rehabilitation App for Articulation Delay.
NCT07613268Speech Sound Disorder, Language Development Disorders, Phonological Disorder
Seoul National University Bundang Hospital
Not applicable
48
Seongnam-si
2026-05
Active, closed
Executive Function Training Program for Children With ASD
NCT07801833Autism Spectrum Disorder
Seoul National University Bundang Hospital
Not applicable
40
Seongnam-si
2026-03-12
Recruiting
Seoul National University Bundang Hospital
Observational
80
Seongnam-si
2026-03-11
Not yet open
Surface Electromyographic Analysis of Normal Swallowing in Children: An Exploratory Study
NCT07455279Normal Pediatric Swallowing Physiology, Swallowing Muscle Activation Patterns in Children, Swallowing Function
Seoul National University Bundang Hospital
Observational
30
Seongnam-si
2026-03-09
Active, closed
Seoul National University Bundang Hospital
Not applicable
60
Seoul, Seongnam-si
2026-02-19
Not yet open
Seoul National University Bundang Hospital
Not applicable
20
Seongnam-si
2026-01-30
Recruiting
Seoul National University Bundang Hospital
Observational
360
Seongnam-si
2026-01-22
Recruiting
Seoul National University Bundang Hospital
Phase 2
20
Seongnam-si, Seoul
2025-12-10
Recruiting
Seoul National University Bundang Hospital
Phase 2
130
Busan, Daegu, Gangneung, Seongnam-si, Incheon, Hwasun, Cheongju-si, Seoul
2025-08-27
Active, closed
Seoul National University Bundang Hospital
Not applicable
88
Seongnam-si
2025-08-01
Active, closed
Study for Pregnant Women With Insomnia Using Sleep Inducing Digital Sound Application
NCT07266415Insomnia, Pregnancy, First Trimester, Pregnancy, Second Trimester
Seoul National University Bundang Hospital
Not applicable
30
Seongnam-si
2025-06-24
Recruiting
Clinical Outcomes of Primary Cementless Total Hip Arthroplasty Using the Collarless Actis Stem
NCT07828080Osteoarthritis, Hip, Femur Head Necrosis, Femoral Neck Fractures, Arthritis Rheumatoid
Seoul National University Bundang Hospital
Not applicable
210
Seongnam-si
2025-06-18
Recruiting
Seoul National University Bundang Hospital
Observational
150
Seongnam-si
2025-06-13
Recruiting
SWEEP: Shuttle Walking Test for Exercise Evaluation in Pulmonary Resection
NCT07102589COPD, ILD, Bronchiectasis, Lung Cancer NOS
Seoul National University Bundang Hospital
Observational
100
Seongnam-si
2025-06-01
Active, closed
Seoul National University Bundang Hospital
Phase 1
12
Seongnam-si
2025-05-14
Recruiting
Seoul National University Bundang Hospital
Observational
500
Seongnam-si
2025-04-21
Active, closed
Seoul National University Bundang Hospital
Not applicable
100
Seongnam-si
2025-02-26
Recruiting
Intra-lesional Tumor Boost for Bulky Cervical Cancer
NCT07435376Cervical Cancer, Squamous Cell Carcinoma of Cervix
Seoul National University Bundang Hospital
Phase 2
17
Seongnam-si
2025-02-23
Not yet open
Seoul National University Bundang Hospital
Observational
90
Seongnam-si
2025-01-07
Recruiting
Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes
NCT06989697Type 2 Diabets Mellitus, Cognitive Ability, General
Seoul National University Bundang Hospital
Phase 3
80
Seongnam-si
2025-01-01
Recruiting
Seoul National University Bundang Hospital
Phase 4
120
Seongnam-si
2025-01-01
Not yet open
Deep Learning Model for Predicting a Peripheral Venous Waveform-based Pulse Pressure Variation
NCT06734650Peripheral Vein, Arterial Wave Reflections, Pulse Pressure Variation, Stroke Volume Variation
Seoul National University Bundang Hospital
Observational
150
Seongnam-si
2024-12-28
Not yet open
Peripheral Venous Pressure Variation, Pulse Pressure Variation and Pleth Variability Index for Fluid Responsiveness
NCT06733389Pulse Pressure Variation, Stroke Volume Variation, Pleth Variability Index
Seoul National University Bundang Hospital
Observational
150
Seongnam-si
2024-12-28
Recruiting
Seoul National University Bundang Hospital
Not applicable
107
Seongnam-si
2024-06-12
Recruiting
Clopidogrel Versus Cilostazol on Vessels
NCT06402747Type 2 Diabetes, Atherosclerosis
DrugsCilostazol·Clopidogrel
Seoul National University Bundang Hospital
Phase 4
120
Seongnam-si
2024-04-16
Recruiting
Seoul National University Bundang Hospital
Phase 4
120
Seongnam-si
2024-02-01
Recruiting
Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy
NCT07796217Cardiac Event, Coronary Artery Disease, Peripheral Artery Disease, Bleeding
DrugClopidogrel
Seoul National University Bundang Hospital
Phase 4
2,758
Seongnam-si
2023-11-15
Recruiting
Seoul National University Bundang Hospital
Phase 4
56
Seongnam-si
2023-06-01
Active, closed
Seoul National University Bundang Hospital
Not applicable
40
Seongnam-si
2023-04-07
Recruiting
Seoul National University Bundang Hospital
Observational
1,240
Daegu, Gyeonggi-do, Hwasun, Ilsan, Jinju, Seongnam-si, Seoul, Yangsan
2023-04-01
Recruiting
Dual-chamber Patient-controlled Analgesia for Postoperative Recovery
NCT07051109Morbid Obesity, PCA, Analgesia, PONV
Seoul National University Bundang Hospital
Not applicable
92
Seongnam-si
2022-10-11
Recruiting
Seoul National University Bundang Hospital
Phase 4
105
Seongnam-si
2022-10-01
Recruiting
Seoul National University Bundang Hospital
Phase 2
28
Seongnam-si
2022-04-01
Recruiting
Seoul National University Bundang Hospital
Not applicable
338
Seongnam-si
2022-02-27
Recruiting
Seoul National University Bundang Hospital
Phase 3
130
Seongnam-si
2022-01-03
Active, closed
Seoul National University Bundang Hospital
Not applicable
108
Seongnam-si
2021-11-15
Active, closed
Seoul National University Bundang Hospital
Not applicable
141
Seongnam-si
2021-02-01
Recruiting
Tegoprazan-containing Sequential for H. Pylori
NCT06382493Helicobacter Pylori Infection
Seoul National University Bundang Hospital
Not applicable
400
Seongnam-si
2021-02-01
Recruiting
Seoul National University Bundang Hospital
Not applicable
100
Seongnam-si
2020-07-01
Recruiting
Clinicopathological Characteristics of Colon Cancer in Young Age
NCT05365412Colo-rectal Cancer, Molecular Pathway Deregulation
Seoul National University Bundang Hospital
Observational
1,400
Seongnam-si
2019-01-01
Active, closed
Seoul National University Bundang Hospital
Observational
582
Seongnam-si
2015-03-01
Recruiting
Seoul National University Bundang Hospital
Not applicable
600
Seongnam-si
2014-08
Recruiting
Predictors of Prognosis in IBD Patients
NCT05653011Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn Disease
Seoul National University Bundang Hospital
Observational
100
Seongnam-si
2013-03-11
Recruiting
Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea
NCT05247112Helicobacter Pylori Infection, Helicobacter Pylori Associated Gastrointestinal Disease, Helicobacter Pylori Infection, Susceptibility to, Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation
Seoul National University Bundang Hospital
Observational
2,000
Seongnam-si
2003-07-01
Active, closed
Seoul National University Bundang Hospital
Observational
24,000
Seongnam-si
2003-03-01
Rows per page Showing 1–51 of 51
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/seongnam-si

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,365 studies in total at the last sync on 11 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 51 of those studies with a site in Seongnam-si that also match the filters currently applied.

How many clinical trials are recruiting in Seongnam-si?

29 of the 51 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:17 UTC sync. A further 9 have not yet opened recruitment, 11 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Seongnam-si), 51 studies
PhaseStudiesRecruitingShare
Not applicable20739.2%
Observational15929.4%
Phase 48715.7%
Phase 2447.8%
Phase 3223.9%
Phase 1102%
Phase 1/2102%

Most active sponsors

Lead sponsors with the most studies (Seongnam-si)
Lead sponsorStudiesRecruiting
Seoul National University Bundang Hospital5129
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.